Search clinical trials for: glycopyrrolate, 4.0%

Total 8328 results

Journey Medical Corporation

Completed

A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States
Journey Medical Corporation

Completed

Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States, Canada
Sunovion Respiratory Development Inc.

Completed

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease
Universitaire Ziekenhuizen KU Leuven

Completed

Suture Materials: an Evaluation

Suture Materials
Sunovion Respiratory Development Inc.

Completed

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease
AO GENERIUM

Recruiting

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Metabolic Diseases | Mucopolysaccharidosis Type II

Russian Federation
BioMarin Pharmaceutical

Terminated

Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Belgium, Netherlands, France, United Kingdom, Italy
Betta Pharmaceuticals Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Psoriasis

China
Novartis

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
Celtic Pharma Development Services

Completed

Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers

Edema

United States
Eunah Cho, MD

Completed

Benefits of Glycopyrrolate on Intubation With Rigid-videostylet (OptiScope®)

Cholecystitis, Acute

Korea, Republic of
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative (RETHINC)

COPD (Chronic Obstructive Pulmonary Disease)

United States
Bausch Health Americas, Inc.

Completed

(C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Zimmer Biomet

Enrolling by invitation

MDR - Biomet Cannulated Screws

Fractures, Bone | Fracture Multiple

United States
Rothman Institute Orthopaedics

Completed

A Comparison of Steel and Bioabsorbable Screw Fixation of Lisfranc Foot Injuries (Lisfranc)

Joint Instability

United States
Santen Inc.

Completed

A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration (PAVE)

Age-Related Macular Degeneration

United States
aTyr Pharma, Inc.
Foundation for Sarcoidosis Research

Completed

Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
James J. Peters Veterans Affairs Medical Center

Unknown

Use of Prokinetics During Inpatient Bowel Care for SCI Patients

Neurogenic Bowel | Spinal Cord Injury

United States
Beijing Chaoyang District Centre for Disease Control...

Completed

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older

Herpes Zoster
Tanta University

Unknown

The Off Label Use of Glycopyrrolate in the Adults Intensive Care Unit.

Effect of Drugs

Saudi Arabia
Shionogi

Completed

Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions

Cerebral Palsy | Sialorrhea | Mental Retardation | Neurological Conditions

United States
University of California, San Francisco

Withdrawn

Evaluating the Feasibility of Disseminating a Novel Mobile Platform to Treat Depression (PRIME-D)

Depression

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Belgium, Netherlands, Canada, United States
Chiesi Farmaceutici S.p.A.

Completed

Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients (Trigon)

Chronic Obstructive Pulmonary Disease

Bulgaria, Germany, Poland, United Kingdom
US Department of Veterans Affairs

Completed

Intranasal Administration of a Prokinetic for Bowel Evacuation in Persons With SCI (IN NEO)

SCI

United States
University of Alabama, Tuscaloosa

Unknown

ACAR Brain Health Intervention Study

Aging Well

United States
Memorial Sloan Kettering Cancer Center

Completed

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

Surgery

United States
James J. Peters Veterans Affairs Medical Center

Completed

Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI

Neurogenic Bowel | Spinal Cord Injury

United States
Regado Biosciences, Inc.

Completed

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD (SC101)

Healthy Volunteer

United States
The Cleveland Clinic

Recruiting

Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block

Neuromuscular Blockade

United States
Radboud University Medical Center

Unknown

Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular Blockade (SFINX)

Anesthesia Recovery Period

Netherlands
Mansoura University

Completed

14.0- 3.0- 3.0- η Protein With Rheumatoid Arthritis

Disease Activity

Egypt
Rabin Medical Center
Medtronic; GIF

Completed

An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes

Diabetes Mellitus, Type 1

Germany, Israel
Duke University
Medartis AG

Completed

Prospective Subtalar, Double, or Triple Arthrodesis Study With CCS Screws

Post-traumatic Osteoarthritis, Unspecified Ankle and Foot | Localized, Primary Osteoarthritis of the Ankle and/or Foot

United States
James J. Peters Veterans Affairs Medical Center

Completed

Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI (TWBC)

Constipation | Spinal Cord Injuries | Neurogenic Bowel

United States
NuSirt Biopharma

Completed

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

Obesity

United States
University of Saskatchewan

Completed

Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve

Asthma

Canada
American University of Beirut Medical Center

Completed

"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"

Anesthesia Recovery

Lebanon
Tel-Aviv Sourasky Medical Center

Completed

Validation of Serenno CUO and IAP Measuring Device

Laparoscopic Surgery | Urinary Catheter

Israel
Taipei Veterans General Hospital, Taiwan

Not yet recruiting

Enhanced Recovery After Surgery for Anterior Cervcial Spine Surgeries in Elderly Patients

Other Fusion of Spine, Cervical Region
Northern Sydney Anaesthesia Research Institute
Merck Sharp & Dohme LLC; Northern Sydney and Central Coast Area Health Service

Terminated

Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine (P-PERSON)

Pulmonary Complications

Australia
University of Texas Southwestern Medical Center
Merck Sharp & Dohme LLC

Completed

Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients

Neuromuscular Blockade

United States
University Hospital, Ghent

Completed

Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children

Urological Surgery

Belgium
West Virginia University

Recruiting

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

Microlaryngoscopy | Rigid Bronchoscopy

United States
James J. Peters Veterans Affairs Medical Center

Active, not recruiting

Pharmacokinetics of Neostigmine and Glycopyrrolate

Constipation | Spinal Cord Injuries | Neurogenic Bowel | Fecal Incontinence

United States
Rajesh Deshar

Completed

Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia

Hemodynamic Instability | Effect of Drug | Post-spinal Hypotension | Glycopyrrolate

Nepal
Sunovion Respiratory Development Inc.

Completed

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Ciusss de L'Est de l'Île de Montréal

Completed

Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium (SUGANEO)

Neuromuscular Blockade

Canada
Cerevel Therapeutics, LLC

Recruiting

A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

Apathy in Dementia

United States, Canada
Matias Vested

Recruiting

Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients

Neuromuscular Blockade, Residual

Denmark

3

Subscribe